ScholarIQanswers from OpenAlex & ORCID
Helena Marzo‐Ortega
ResearcherPublications, citations & collaboration network
Helena Marzo‐Ortega is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Helena Marzo‐Ortega have?
ScholarIQindexed works
Helena Marzo‐Ortega has 500 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Helena Marzo‐Ortega have?
ScholarIQcitation count
Helena Marzo‐Ortega has 20,609 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Helena Marzo‐Ortega?
ScholarIQh-index
Helena Marzo‐Ortega has an h-index of 70 in OpenAlex.
What is the i10-index of Helena Marzo‐Ortega?
ScholarIQi10-index
Helena Marzo‐Ortega has an i10-index of 173 in OpenAlex.
What is the ORCID of Helena Marzo‐Ortega?
ScholarIQorcid
The ORCID for Helena Marzo‐Ortega is on the source record.
What is the OpenAlex record for Helena Marzo‐Ortega?
ScholarIQopenalex
The OpenAlex for Helena Marzo‐Ortega is on the source record.
What are the most-cited papers on Helena Marzo‐Ortega?
ScholarIQmost cited works
European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update
Laure Gossec, Josef S Smolen, Sofía Ramiro, M. De Wit, Maurizio Cutolo, Maxime Dougados, Paul Emery, R. Landewé, Susan Oliver, Daniel Aletaha, Neil Betteridge, Jürgen Braun, Gerd R Burmester, Juan D. Cañete, Nemanja Damjanov, Oliver FitzGerald, Emma Haglund, Philip Helliwell, T. K. Kvien, Rik Lories, Thomas A. Luger, Mara Maccarone, Helena Marzo‐Ortega, Dennis McGonagle, Iain B. McInnes, Ignazio Olivieri, Karel Pavelká, Georg Schett, Joachim Sieper, Filip Van den Bosch, Douglas J. Veale, J. Wollenhaupt, A. Zink, Désirée van der Heijde
Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial
Peter Nash, Bruce Kirkham, Masato Okada, Proton Rahman, Benard Combe, Gerd‐Ruediger Burmester, David Adams, Lisa Kerr, Chin Lee, Catherine L Shuler, Mark C. Genovese, Khalid Ahmed, Jeffrey Alper, N Barkham, Ralph E. Bennett, Francisco J. Blanco, Ricardo Blanco Alonso, Howard Blumstein, Michael S. Brooks, Gerd‐Rüdiger Burmester, Patricia Cagnoli, Paul H. Caldron, Alain Cantagrel, Der‐Yuan Chen, Melvin Churchill, Christine E. Codding, Benard Combe, Peter M.G. Deane, José Del Giudice, Atul Deodhar, Rajat K. Dhar, Eva Dokoupilová, Rita M. Egan, Andrea Everding, E. Galíndez, Mark C. Genovese, David H. Goddard, Alice B. Gottlieb, Philippe Goupille, Robert Griffin, Ramesh C. Gupta, Stephen Hall, Kalpita Hatti, Mary P. Howell, Yu‐Huei Huang, Ramina Jajoo, Namieta M. Janssen, Uta Kiltz, Alan Kivitz, Steven J. Klein, Mariusz Korkosz, Roshan Kotha, Joel M. Kremer, C Lue, José Luís Marenco de la Fuente, Helena Marzo‐Ortega, Jordi Gratacós Masmitja, Philip J. Mease, Pier Luigi Meroni, Eric C. Mueller, Anupama Nandagudi, Peter Nash, Antonio Fernández‐Nebro, C. Michael Neuwelt, Ana‐Maria Orbai, Meera R. Oza, Deborah L. Parks, Debendra Pattanaik, Maria Rell‐Bakalarska, David Rosmarin, Euthalia Roussou, Anna I. Rychlewska-Hanczewksa, David Sikes, Michael T. Stack, Prashanth Sunkureddi, Hasan Tahir, Diamant Thaçi, Tsen‐Fang Tsai, Anthony Turkiewicz, L. Unger, Raúl Veiga Cabello, Ulf Wagner, Cheng-Chung Wei, Alvin F. Wells, Peter Youssef, Agnieszka Zielińska